Found: 1

Select item for more details and to access through your institution.

  • GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37465-1
    By:
    • Kasiewicz, Lisa N.;
    • Biswas, Souvik;
    • Beach, Aaron;
    • Ren, Huilan;
    • Dutta, Chaitali;
    • Mazzola, Anne Marie;
    • Rohde, Ellen;
    • Chadwick, Alexandra;
    • Cheng, Christopher;
    • Garcia, Sara P.;
    • Iyer, Sowmya;
    • Matsumoto, Yuri;
    • Khera, Amit V.;
    • Musunuru, Kiran;
    • Kathiresan, Sekar;
    • Malyala, Padma;
    • Rajeev, Kallanthottathil G.;
    • Bellinger, Andrew M.
    Publication type:
    Article